talimogene laherparepvec - Generic Medications
Browse 1 brand name versions of talimogene laherparepvec. Review brand names, dosage forms, strengths, and linked product records.
IMLYGIC (talimogene laherparepvec) is a sterile suspension for intralesional injection. IMLYGIC is a live, attenuated HSV-1 that has been genetically modified to express huGM-CSF. The parental virus for IMLYGIC was a primary isolate, which was subsequently altered using recombinant methods to result in gene deletions and insertions. Each vial contains 1 mL deliverable volume of IMLYGIC at either 1 x 10 6 (1 million) PFU per mL or 1 × 10 8 (100 million) PFU per mL concentrations and the following excipients: di-sodium hydrogen phosphate dihydrate (15.4 mg), sodium dihydrogen phosphate dihydrate (2.44 mg), sodium chloride (8.5 mg), myo-inositol (40 mg), sorbitol (20 mg), and water for injection. The 10 6 (1 million) PFU per mL vial of IMLYGIC contains a clear to semi-translucent liquid following thaw from its frozen state. The 10 8 (100 million) PFU per mL vial of IMLYGIC contains a semi-translucent to opaque liquid following thaw from its frozen state. The liquid in each vial may contain white, visible, variously shaped, virus-containing particles. Each vial of IMLYGIC may also contain residual components of VERO cells including DNA and protein and trace quantities of fetal bovine serum. The product contains no preservative.
About talimogene laherparepvec Generic Drugs
This collection groups medications in our database under the generic name talimogene laherparepvec. It currently includes 1 matching listing.
What You Can Review
Use this page to compare the set of products we have indexed for this generic name. Each result links to more detailed product information and related landing pages.
Safety Information
Always consult a qualified healthcare professional before starting, stopping, or switching any medication. The information on this page is educational and should not replace medical advice.